NE

NEOZYME CORP

  • CIK: 0000866817
  • EIN: 04-3093642
  • Business address: ONE KENDALL SQUARE, CAMBRIDGE, Massachusetts, 02139

Information

  • Mailing address
    , , Delaware,
  • Phone
    6172527500
  • State location
    Massachusetts
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
  • Filings
    N/A

About NEOZYME CORP

NEOZYME CORP (CIK: 0000866817) is an American company incorporated in the state of Massachusetts. Head office is located at ONE KENDALL SQUARE, CAMBRIDGE, Massachusetts, 02139. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. NEOZYME CORP is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by NEOZYME CORP

Filings Format Description Filed/Effective File/Film Number
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0000068100-95-000258 ( Act) Size: KB		 Mar-10-1995

005-41298

95520029
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0000068100-95-000043 ( Act) Size: KB		 Feb-15-1995

005-41298

95511113
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0000068100-95-000016 ( Act) Size: KB		 Jan-10-1995

005-41298

95500800
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0000728889-94-000010 ( Act) Size: KB		 Feb-08-1994

005-41298

94505096

Recent 20 filings. View all NEOZYME CORP filings

Reviews

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Frequently Asked Questions

Tags:

  • NEOZYME CORP overview
  • NEOZYME CORP job
  • NEOZYME CORP stock
  • NEOZYME CORP ownership
  • NEOZYME CORP CEO
  • NEOZYME CORP documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Asep Medical Holdings Inc.
Update: May 30, 2024
ZYMETX INC
Update: Aug 26, 2022
ZyCare, Inc.
Update: Aug 26, 2022
WORLDWIDE MEDICAL CORP/CA/
Update: Aug 25, 2022
WILLS GERARD A
Update: Aug 25, 2022
WIDDER KENNETH J
Update: Aug 25, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 2032 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 2011 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 3333 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 2649 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 4174 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 1529 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 4470 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 3793 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 2677 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by